• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, September 13, 2024

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from NeurologyToday referenced a study published in the August 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Care Management Improves Total Cost of Care for Patients With Dementia,” found that a managed Medicare population had significant financial benefit from a collaborative dementia care program.

An article from HIT Consultant referenced another study published in the August 2024 issue of AJMC. The study, “A Machine Learning Technology for Addressing Medication-Related Risk in Older, Multimorbid Patients,” showed that the FeelBetter system was able to stratify older patients with multimorbidity who were at risk of increased emergency department use and hospitalizations.

The study titled “Beyond Average Spending: Distributional and Seasonal Commercial Insurance Trends, 2012-2021,” published in the September 2024 issue of AJMC, was referenced in an article from Benefits Pro. The study determined that insurance is working well to protect the highest spenders at the cost of reducing insurance generosity for spenders elsewhere in the distribution.

A roundup from AI in Healthcare referenced coverage from the European Respiratory Society Congress 2024 published on AJMC.com, the website of AJMC. The article, “Ethical Considerations for AI in Clinical Decision-Making,” summarized a panel about the ethical concerns of using artificial intelligence (AI) when it comes to the autonomy of the patient, as well as equity, transparency, and sustainability.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Dan Nardi
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.